Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a mushroom compound turn back the clock on aging?

NCT ID NCT07750002

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether a daily supplement called NVTIA® ergothioneine can improve markers of healthy aging and skin health in healthy adults aged 35 to 55. Over 12 weeks, half the participants will take the supplement and half will take a placebo, with neither group knowing which they receive. Researchers will measure oxidative stress, skin elasticity, hydration, and inflammation to see if the supplement offers any benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NVTIA® ergothioneine, a branded dietary supplement
What this could lead to
If it works, this supplement could offer a simple way to support healthy aging and skin health in middle-aged adults.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The supplement may not produce meaningful changes, and any benefits could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must meet all of the following criteria: * Male or female adults aged 35 to 55 years. * Generally healthy as determined by medical history, physical examination, and screening assessments. * Body Mass Index (BMI) between 18.5 and 29.9 kg/m². * Willing and able to provide written informed consent. * Willing to maintain their usual diet, physical activity, and lifestyle throughout the study period. * Willing to avoid the use of other antioxidant, anti-aging, or nutritional supplements during the study period unless approved by the investigator. * Able and willing to comply with all study procedures and scheduled visits. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: * History of clinically significant cardiovascular, hepatic, renal, gastrointestinal, endocrine, neurological, or psychiatric disease. * Current diagnosis of diabetes mellitus requiring medication. * Active inflammatory or autoimmune disease. * History of malignant disease within the previous five years. * Pregnancy, breastfeeding, or planning pregnancy during the study period. * Known allergy or hypersensitivity to ergothioneine or any ingredient of the study product. * Use of antioxidant supplements, anti-aging supplements, or investigational products within 30 days before enrollment. * Current smoker or history of heavy alcohol consumption. * Participation in another clinical trial within the previous 30 days. * Any medical condition or laboratory abnormality that, in the opinion of the investigator, may interfere with study participation or interpretation of study results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dhaka Central International Medical College & Hospital

    RECRUITING

    Dhaka, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.